CEO Interviews
Popular
Biotech
Anna Gluskin, CEO of Eastgate BioTech (OTC: ETBI) discusses positive results and how they are ready to take the Insulin market by storm.
“We’re doing a number of trials in Pakistan right now and the results that we announced just the other day; the end of the month, we’re showing a very good efficacy in absorption of product without injection.” […]